919 related articles for article (PubMed ID: 17991708)
1. Carbon monoxide liberated from carbon monoxide-releasing molecule CORM-2 attenuates inflammation in the liver of septic mice.
Cepinskas G; Katada K; Bihari A; Potter RF
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G184-91. PubMed ID: 17991708
[TBL] [Abstract][Full Text] [Related]
2. Role of CO-releasing molecules liberated CO in attenuating leukocytes sequestration and inflammatory responses in the lung of thermally injured mice.
Sun B; Sun H; Liu C; Shen J; Chen Z; Chen X
J Surg Res; 2007 May; 139(1):128-35. PubMed ID: 17292406
[TBL] [Abstract][Full Text] [Related]
3. [Molecular mechanism of inhibition of early pulmonary injury and inflammatory response by exogenous carbon monoxide: experiment with mice].
Sun BW; Chen X; Chen ZY; Katada K; Cepinskas G
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3148-51. PubMed ID: 18269877
[TBL] [Abstract][Full Text] [Related]
4. [The inhibitory effects of extrinsic carbon monoxide-releasing molecules II on inflammatory responses in liver of mice with severe burns].
Sun BW; Chen X; Chen ZY; Kazuhiro K; Gediminas C
Zhonghua Shao Shang Za Zhi; 2007 Jun; 23(3):179-83. PubMed ID: 18019055
[TBL] [Abstract][Full Text] [Related]
5. Exogenous carbon monoxide attenuates inflammatory responses in the small intestine of septic mice.
Wang X; Cao J; Sun BW; Liu DD; Liang F; Gao L
World J Gastroenterol; 2012 Oct; 18(40):5719-28. PubMed ID: 23155312
[TBL] [Abstract][Full Text] [Related]
6. Effect of carbon monoxide-releasing molecules II-liberated CO on suppressing inflammatory response in sepsis by interfering with nuclear factor kappa B activation.
Qin W; Zhang J; Lv W; Wang X; Sun B
PLoS One; 2013; 8(10):e75840. PubMed ID: 24116078
[TBL] [Abstract][Full Text] [Related]
7. Preconditioning of carbon monoxide releasing molecule-derived CO attenuates LPS-induced activation of HUVEC.
Sun B; Zou X; Chen Y; Zhang P; Shi G
Int J Biol Sci; 2008 Aug; 4(5):270-8. PubMed ID: 18726003
[TBL] [Abstract][Full Text] [Related]
8. CORM-3-derived CO modulates polymorphonuclear leukocyte migration across the vascular endothelium by reducing levels of cell surface-bound elastase.
Mizuguchi S; Stephen J; Bihari R; Markovic N; Suehiro S; Capretta A; Potter RF; Cepinskas G
Am J Physiol Heart Circ Physiol; 2009 Sep; 297(3):H920-9. PubMed ID: 19561312
[TBL] [Abstract][Full Text] [Related]
9. [Inhibitive effect of exogenous carbon monoxide-releasing molecules 2 on tissue factor expression in sepsis].
Sun BW; Shi GS; Zhang P; Zou XQ; Chen X
Zhonghua Shao Shang Za Zhi; 2009 Apr; 25(2):111-4. PubMed ID: 19799035
[TBL] [Abstract][Full Text] [Related]
10. Exogenous carbon monoxide suppresses Escherichia coli vitality and improves survival in an Escherichia coli-induced murine sepsis model.
Shen WC; Wang X; Qin WT; Qiu XF; Sun BW
Acta Pharmacol Sin; 2014 Dec; 35(12):1566-76. PubMed ID: 25399652
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment of human cerebrovascular endothelial cells with CO-releasing molecule-3 interferes with JNK/AP-1 signaling and suppresses LPS-induced proadhesive phenotype.
Serizawa F; Patterson E; Potter RF; Fraser DD; Cepinskas G
Microcirculation; 2015 Jan; 22(1):28-36. PubMed ID: 25098198
[TBL] [Abstract][Full Text] [Related]
12. Mediators released from LPS-challenged lungs induce inflammatory responses in liver vascular endothelial cells and neutrophilic leukocytes.
Markovic N; McCaig LA; Stephen J; Mizuguchi S; Veldhuizen RA; Lewis JF; Cepinskas G
Am J Physiol Gastrointest Liver Physiol; 2009 Dec; 297(6):G1066-76. PubMed ID: 19815624
[TBL] [Abstract][Full Text] [Related]
13. Carbon monoxide liberated from CO-releasing molecule (CORM-2) attenuates ischemia/reperfusion (I/R)-induced inflammation in the small intestine.
Katada K; Bihari A; Mizuguchi S; Yoshida N; Yoshikawa T; Fraser DD; Potter RF; Cepinskas G
Inflammation; 2010 Apr; 33(2):92-100. PubMed ID: 19842024
[TBL] [Abstract][Full Text] [Related]
14. 4-O-methylgallic acid down-regulates endothelial adhesion molecule expression by inhibiting NF-kappaB-DNA-binding activity.
Lee G; Na HJ; Namkoong S; Jeong Kwon H; Han S; Ha KS; Kwon YG; Lee H; Kim YM
Eur J Pharmacol; 2006 Dec; 551(1-3):143-51. PubMed ID: 17027748
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of leukocytes sequestration by carbon monoxide-releasing molecules: liberated carbon monoxide in the liver of thermally injured mice.
Sun BW; Chen ZY; Chen X; Liu C
J Burn Care Res; 2007; 28(1):173-81. PubMed ID: 17211222
[TBL] [Abstract][Full Text] [Related]
16. The carbon monoxide-releasing molecule CORM-2 inhibits the inflammatory response induced by cytokines in Caco-2 cells.
Megías J; Busserolles J; Alcaraz MJ
Br J Pharmacol; 2007 Apr; 150(8):977-86. PubMed ID: 17339836
[TBL] [Abstract][Full Text] [Related]
17. Benznidazole treatment attenuates liver NF-κB activity and MAPK in a cecal ligation and puncture model of sepsis.
Ronco MT; Manarin R; Francés D; Serra E; Revelli S; Carnovale C
Mol Immunol; 2011 Mar; 48(6-7):867-73. PubMed ID: 21269697
[TBL] [Abstract][Full Text] [Related]
18. Carbon monoxide-releasing molecule 3 inhibits myeloperoxidase (MPO) and protects against MPO-induced vascular endothelial cell activation/dysfunction.
Patterson EK; Fraser DD; Capretta A; Potter RF; Cepinskas G
Free Radic Biol Med; 2014 May; 70():167-73. PubMed ID: 24583458
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo effects of the carbon monoxide-releasing molecule, CORM-3, in the xenogeneic pig-to-primate context.
Vadori M; Seveso M; Besenzon F; Bosio E; Tognato E; Fante F; Boldrin M; Gavasso S; Ravarotto L; Mann BE; Simioni P; Ancona E; Motterlini R; Cozzi E
Xenotransplantation; 2009; 16(2):99-114. PubMed ID: 19392725
[TBL] [Abstract][Full Text] [Related]
20. Carbon monoxide from CORM-2 reduces HMGB1 release through regulation of IFN-β/JAK2/STAT-1/INOS/NO signaling but not COX-2 in TLR-activated macrophages.
Tsoyi K; Nizamutdinova IT; Jang HJ; Mun L; Kim HJ; Seo HG; Lee JH; Chang KC
Shock; 2010 Dec; 34(6):608-14. PubMed ID: 20442692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
